Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001172661-26-000689·Bicara Therapeutics Inc.
Schedule 13G ownership disclosure
Bicara Therapeutics Inc
Common Stock, $0.0001 par value · CUSIP: 055477103
Event date: 2026-02-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deep Track Capital, LP
Shares: 2,750,000.00 · Class: 5.02%
- Deep Track Biotechnology Master Fund, Ltd.
Shares: 2,750,000.00 · Class: 5.02%
- David Kroin
Shares: 2,750,000.00 · Class: 5.02%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-26-000689
- Form type
- SCHEDULE 13G
- Filer
- Bicara Therapeutics Inc.
- CIK
- CIK 2023658
- Filed
- Feb 12, 2026
- Reporting period
- Feb 05, 2026
- Description
- Schedule 13G beneficial ownership